Global Health Limited Announces 22nd AGM on Sep 16, 2026, to Discuss FY26 Results & Dividend
Global Health Limited's 22nd AGM is scheduled for September 16, 2026, to approve FY26 financial statements. A final dividend of ₹0.50 per equity share is proposed. The meeting will also address director re-election and cost auditor remuneration of ₹12.50 Lakhs. Remote e-voting is available from September 12-15, 2026.
The AGM notice is important for shareholders as it details financial results, dividend proposals, and director appointments. The proposed dividend and the discussion of financial statements have a direct impact on shareholder value and governance.
The announcement is a routine notice for the Annual General Meeting and related financial disclosures and dividend proposal. It does not contain any significantly positive or negative news.
Global Health Limited (MEDANTA) has announced its 22nd Annual General Meeting (AGM) will be held on Wednesday, September 16, 2026, at 12:00 Noon (IST) via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting will address several key items, including the consideration and adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the Board of Directors' and Auditors' reports.
Furthermore, the company proposes to declare a final dividend of ₹0.50 per equity share for the financial year ended March 31, 2026. Shareholders will also vote on the appointment of a Director, Mr. Pankaj Sahni, who retires by rotation and offers himself for re-election. Special business includes the approval of remuneration payable to the Cost Auditors, M/s. Ramanath Iyer & Co., for the Financial Year 2026-27, set at ₹12.50 Lakhs (excluding applicable taxes and out-of-pocket expenses).
The notice of AGM, along with the Annual Report for the financial year 2025-26, has been made available on the company's website and the stock exchanges' websites. The company is facilitating remote e-voting for shareholders, with the remote e-voting period commencing on Saturday, September 12, 2026, at 09:00 A.M. and concluding on Tuesday, September 15, 2026, at 05:00 P.M. The record date for determining entitlement to the final dividend is August 14, 2026.
What to do with a filing like this
Global Health Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.